Norcod (NCOD) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
26 Feb, 2026Executive summary
Q4 revenue reached NOK 123 million, with full-year turnover at NOK 444 million, up 12% year-over-year despite lower harvesting volumes.
Operating loss for Q4 was NOK 47 million, mainly due to extraordinary mortality, including NOK 43 million in one-off costs.
Jerónimo Martins became a key shareholder with an 80% stake, providing access to major European retailers.
Over 90% of Q4 harvest achieved superior quality; zero escapes reported throughout 2025.
1,737 tonnes harvested in Q4 and 7,723 tonnes for the year.
Financial highlights
EBIT margin improved by 12.5% year-over-year; adjusted EBIT margin up 33% excluding non-recurring mortality costs.
Q4 net loss was NOK 54 million, compared to NOK 41 million in the same quarter last year.
Production cost at sea increased to just over NOK 51 per kilo, up from NOK 46 per kilo last year, mainly due to mortality.
Available credit and cash at hand increased to NOK 103 million after a successful private placement.
Total assets at Q4-25 were NOK 608 million, down from NOK 674 million in Q4-24, mainly due to lower biological assets.
Outlook and guidance
Planned 2026 harvest volume revised to 5,800MT, with significant volume increases projected for 2027.
2026 expected as a transitional year; marked volume and profitability improvements anticipated from 2027.
Investment in a fish oil facility at Kråkøy to enhance value extraction, scheduled for summer 2026.
Green Financing Framework established and certified by DNV.
Latest events from Norcod
- Revenue up 6% to NOK 91m, EBIT margin improved 33%, and losses narrowed despite lower volumes.NCOD
Q2 20254 Mar 2026 - Revenue up 121% and operating loss down 34% as harvests and premium market demand surge.NCOD
Q2 202423 Jan 2026 - Revenue up 47%, operating loss down 66%, and NOK 300M in new funding committed.NCOD
Q4 202423 Dec 2025 - Revenue up 17.6% YoY; strategic investment and premium pricing drive growth outlook.NCOD
Q3 202513 Nov 2025 - Revenue up 63% and operating loss narrowed as funding and growth plans advance.NCOD
Q1 202510 Sep 2025 - Q3 revenue surged 229% year-over-year, but losses rose due to heatwave-driven mortality.NCOD
Q3 202413 Jun 2025 - Revenue down 5% but operating loss halved; Norcod boosts equity and enters China.NCOD
Q1 202413 Jun 2025